边缘位置编码运输特异性在小型多药耐药性出口商中
Olive E Burata1, Ever O'Donnell2, Jeonghoon Hyun2
1Program in Chemical Biology, University of Michigan, Ann Arbor, MI 48109.
概括
小型多药性耐药性 (SMR) 载体通过外围突变而不是直接结合部位变化,进化出新的基质特异性. 这项研究阐明了运输功能是如何适应的,并提供了对药物耐药性演变的见解.
科学领域:
- 生物化学 生化学
- 结构生物学 结构生物学
- 分子进化分子进化
背景情况:
- 二次活性运输体利用有限的蛋白质折叠目录来进行多种溶液运输.
- 改变载体中的基质特异性是复杂的,通常需要广泛的结构改造,阻碍了对进化机制的理解.
- 小型多药性耐药性 (SMR) 载体提供了一个简化的模型来研究不断变化的基质特异性的分子基础.
研究的目的:
- 阐明SMR载体中新型基质特异性的出现背后的分子决定因素和机制.
- 设计一个有选择性的SMR传送器,以表现出散乱的四级氨抗菌剂出口.
- 了解突变如何影响基质的多特异性和运输功能.
主要方法:
- 组合性突变发生和深度测序以确定工程活动的关键残留物.
- 用X射线晶体学来确定与变化的特异性相关的结构变化.
- 固体支膜电生理学和结合试验,以表征运输机制.
- 开发一种基于蛋白质体的新型检测方法,用于四级的抗菌运输.
主要成果:
- 确定了工程四级抗菌剂出口所需和足够的分子决定因素.
- 证明基质偏好的变化源于结合口袋的外围突变,而不是直接的相互作用部位.
- 剖析了已识别的残留物对基质多特异性的机制性贡献.
结论:
- 在SMR传送器中,基质杂交是由直接基质结合部位外的残留物调节的.
- 这项研究为新型运输功能和基质特异性的演变提供了分子洞察力.
- 这些发现对理解多药性耐药性和工程传送器活动有意义.
更多相关视频
相关概念视频
ABC Transporters: Exporter
4.3K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.3K
Carrier-Mediated Transport
355
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
355
ABC Transporters: Importer
2.7K
ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
2.7K
Hepatic Drug Clearance: Role of Transporters
54
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
54
Membrane Transporters
10.7K
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
10.7K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
3.7K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.7K


